AARTI PHARMALABS
Back to Income Statement
|
AARTI PHARMALABS Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹217 Cr | ₹193 Cr | ₹122 Cr | ₹-0.01 Cr | ₹-0.01 Cr |
What is the latest Consolidated Net Profit of AARTI PHARMALABS ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2025 | ₹217 Cr |
| Mar2024 | ₹193 Cr |
| Mar2023 | ₹122 Cr |
| Mar2022 | ₹-0.01 Cr |
| Mar2021 | ₹-0.01 Cr |
How is Consolidated Net Profit of AARTI PHARMALABS Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹217 Cr | 12.10 | |
| Mar2024 | ₹193 Cr | 58.28 | |
| Mar2023 | ₹122 Cr | Positive | |
| Mar2022 | ₹-0.01 Cr | Negative | |
| Mar2021 | ₹-0.01 Cr | - | |
Compare Consolidated Net Profit of peers of AARTI PHARMALABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AARTI PHARMALABS | ₹5,344.5 Cr | -4.4% | -17% | -17% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹421,647.0 Cr | 0.1% | -0.4% | 0.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹157,862.0 Cr | -1.1% | -7.1% | 1.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹142,846.0 Cr | 0.2% | -4.5% | 30.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹104,720.0 Cr | 0.2% | -4% | 6% | Stock Analytics | |
| CIPLA | ₹98,795.9 Cr | 0% | -9.1% | -18.5% | Stock Analytics | |
AARTI PHARMALABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AARTI PHARMALABS | -4.4% |
-17% |
-17% |
| SENSEX | -3.5% |
-12.5% |
-6.5% |
You may also like the below Video Courses